Comparison of the MGISEQ-2000 and Illumina HiSeq 4000 sequencing platforms for RNA sequencing.

Genomics & informatics Pub Date : 2019-09-01 Epub Date: 2019-09-27 DOI:10.5808/GI.2019.17.3.e32
Sol A Jeon, Jong Lyul Park, Jong-Hwan Kim, Jeong Hwan Kim, Yong Sung Kim, Jin Cheon Kim, Seon-Young Kim
{"title":"Comparison of the MGISEQ-2000 and Illumina HiSeq 4000 sequencing platforms for RNA sequencing.","authors":"Sol A Jeon,&nbsp;Jong Lyul Park,&nbsp;Jong-Hwan Kim,&nbsp;Jeong Hwan Kim,&nbsp;Yong Sung Kim,&nbsp;Jin Cheon Kim,&nbsp;Seon-Young Kim","doi":"10.5808/GI.2019.17.3.e32","DOIUrl":null,"url":null,"abstract":"<p><p>Currently, Illumina sequencers are the globally leading sequencing platform in the next-generation sequencing market. Recently, MGI Tech launched a series of new sequencers, including the MGISEQ-2000, which promise to deliver high-quality sequencing data faster and at lower prices than Illumina's sequencers. In this study, we compared the performance of two major sequencers (MGISEQ-2000 and HiSeq 4000) to test whether the MGISEQ-2000 sequencer delivers high-quality sequence data as suggested. We performed RNA sequencing of four human colon cancer samples with the two platforms, and compared the sequencing quality and expression values. The data produced from the MGISEQ-2000 and HiSeq 4000 showed high concordance, with Pearson correlation coefficients ranging from 0.98 to 0.99. Various quality control (QC) analyses showed that the MGISEQ-2000 data fulfilled the required QC measures. Our study suggests that the performance of the MGISEQ-2000 is comparable to that of the HiSeq 4000 and that the MGISEQ-2000 can be a useful platform for sequencing.</p>","PeriodicalId":94288,"journal":{"name":"Genomics & informatics","volume":"17 3","pages":"e32"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808641/pdf/","citationCount":"28","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genomics & informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5808/GI.2019.17.3.e32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/9/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 28

Abstract

Currently, Illumina sequencers are the globally leading sequencing platform in the next-generation sequencing market. Recently, MGI Tech launched a series of new sequencers, including the MGISEQ-2000, which promise to deliver high-quality sequencing data faster and at lower prices than Illumina's sequencers. In this study, we compared the performance of two major sequencers (MGISEQ-2000 and HiSeq 4000) to test whether the MGISEQ-2000 sequencer delivers high-quality sequence data as suggested. We performed RNA sequencing of four human colon cancer samples with the two platforms, and compared the sequencing quality and expression values. The data produced from the MGISEQ-2000 and HiSeq 4000 showed high concordance, with Pearson correlation coefficients ranging from 0.98 to 0.99. Various quality control (QC) analyses showed that the MGISEQ-2000 data fulfilled the required QC measures. Our study suggests that the performance of the MGISEQ-2000 is comparable to that of the HiSeq 4000 and that the MGISEQ-2000 can be a useful platform for sequencing.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于RNA测序的MGISEQ-2000和Illumina HiSeq 4000测序平台的比较。
目前,Illumina测序仪是下一代测序市场中全球领先的测序平台。最近,MGI Tech推出了一系列新的测序仪,包括MGISEQ-2000,它承诺以比Illumina测序仪更快、更低的价格提供高质量的测序数据。在这项研究中,我们比较了两种主要测序仪(MGISEQ-2000和HiSeq 4000)的性能,以测试MGISEQ-2000测序仪是否能提供所建议的高质量序列数据。我们用两个平台对四个人类癌症样本进行了RNA测序,并比较了测序质量和表达值。MGISEQ-2000和HiSeq 4000产生的数据显示出高度一致性,Pearson相关系数在0.98至0.99之间。各种质量控制(QC)分析表明,MGISEQ-2000数据符合要求的QC措施。我们的研究表明,MGISEQ-2000的性能与HiSeq 4000相当,MGISEQ-2000可以成为一个有用的测序平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analyzing COVID-19 progression with Markov multistage models: insights from a Korean cohort. Structural insights into antibody-based immunotherapy for hepatocellular carcinoma. DeepDoublet identifies neighboring cell-dependent gene expression. Rore: robust and efficient antioxidant protein classification via a novel dimensionality reduction strategy based on learning of fewer features. Rare disease genomics and precision medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1